Clinical Trials List
2015-08-01 - 2020-03-31
Phase III
Terminated9
ICD-10C92.A0
Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
ICD-10C92
Myeloid leukemia
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ming-Yu Lien Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- - - Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
- Tai-Chung Huang Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
- Chien-Chin Lin Division of Hematology & Oncology
- 林建廷 Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- 徐思淳 Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
- Chien-Yuan Chen Division of Hematology & Oncology
- 陳尹愷 Division of Hematology & Oncology
- 劉家豪 Division of Hematology & Oncology
- SHAN-CHI YU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Wei-Pang Chung Division of Hematology & Oncology
- Sin-Syue Li Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Ya-Ting Hsu Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 楊陽生 Division of Hematology & Oncology
- Chieh-Lin Teng Division of Hematology & Oncology
- 滕傑林 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- Po-Nan Wang Division of Hematology & Oncology
- Tung-Liang Lin Division of Hematology & Oncology
- 高小雯 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
38 participants
-
Global
369 participants
